712-68-5

712-68-5结构式

常用中文名：1,3,4-Thiadiazol-2-amine,5-(5-nitro-2-furanyl)-
常用英文名：1,3,4-Thiadiazol-2-amine,5-(5-nitro-2-furanyl)-
CAS号：712-68-5
分子式：C₆H₄N₄O₃S
分子量：212.18600
发布时间：2017-12-28 17:09:46
更新时间：2024-01-10 14:49:03

英文名	5-(5-nitrofuran-2-yl)-1,3,4-thiadiazol-2-amine
英文别名	Thiafur Tiafur Furidiazina Ph/778 TRIAFUR Furidiazine ASA-140 Furidazina

密度	1.663g/cm3
沸点	437.9ºC at 760 mmHg
分子式	C₆H₄N₄O₃S
分子量	212.18600
闪点	218.7ºC
精确质量	212.00000
PSA	139.00000
LogP	2.39290
折射率	1.685

CHEMICAL IDENTIFICATION

RTECS NUMBER :: XI3600000

CHEMICAL NAME :: 1,3,4-Thiadiazole, 2-amino-5-(5-nitro-2-furyl)-

CAS REGISTRY NUMBER :: 712-68-5

LAST UPDATED :: 199612

DATA ITEMS CITED :: 7

MOLECULAR FORMULA :: C6-H4-N4-O3-S

MOLECULAR WEIGHT :: 212.20

WISWESSER LINE NOTATION :: T5OTJ BNW E- ET5NN DSJ CZ

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 6 gm/kg/46W-I

TOXIC EFFECTS :: Tumorigenic - Carcinogenic by RTECS criteria Gastrointestinal - tumors Skin and Appendages - tumors

REFERENCE :: JNCIAM Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. Volume(issue)/page/year: 54,841,1975

TYPE OF TEST :: TD - Toxic dose (other than lowest)

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 2240 mg/kg/32W-C

TOXIC EFFECTS :: Tumorigenic - neoplastic by RTECS criteria Lungs, Thorax, or Respiration - tumors Reproductive - Tumorigenic effects - uterine tumors

REFERENCE :: FEPRA7 Federation Proceedings, Federation of American Societies for Experimental Biology. (Bethesda, MD) V.1-46, 1942-87. Volume(issue)/page/year: 29,817,1970 *** REVIEWS *** IARC Cancer Review:Animal Sufficient Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- Volume(issue)/page/year: 7,143,1974 IARC Cancer Review:Human No Adequate Data IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- Volume(issue)/page/year: 7,143,1974 IARC Cancer Review:Group 2B IMSUDL IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- Volume(issue)/page/year: 7,56,1987 TOXICOLOGY REVIEW CCSUDL Carcinogenesis--A Comprehensive Survey. (Raven Press, 1185 Ave. of the Americas, New York, NY 10036) V.1- 1976- Volume(issue)/page/year: 4,171,1978

海关编码	2934999090

831-71-0

~86%

712-68-5

文献：Foroumadi, Alireza; Daneshtalab, Mohsen; Shafiee, Abbas Arzneimittel-Forschung/Drug Research, 1999 , vol. 49, # 12 p. 1035 - 1038

146827-83-0

~65%

712-68-5

文献：Chauviere, Gerard; Bouteille, Bernard; Enanga, Bertin; De Albuquerque, Cristina; Croft, Simon L.; Dumas, Michel; Perie, Jacques Journal of Medicinal Chemistry, 2003 , vol. 46, # 3 p. 427 - 440

698-63-5

712-68-5

92-55-7

712-68-5

文献：Foroumadi, Alireza; Pournourmohammadi, Shirin; Soltani, Fatemeh; Asgharian-Rezaee, Mitra; Dabiri, Shahriar; Kharazmi, Arsalan; Shafiee, Abbas Bioorganic and Medicinal Chemistry Letters, 2005 , vol. 15, # 8 p. 1983 - 1985

1673-59-2

712-68-5

文献：Sherman,W.R. Journal of Organic Chemistry, 1961 , vol. 26, p. 88 - 95

92-55-7

79-19-6

712-68-5

文献：Tahghighi, Azar; Marznaki, Farzane Rezazade; Kobarfard, Farzad; Dastmalchi, Siavoush; Mojarrad, Javid Shahbazi; Razmi, Sepideh; Ardestani, Sussan Kabudanian; Emami, Saeed; Shafiee, Abbas; Foroumadi, Alireza European Journal of Medicinal Chemistry, 2011 , vol. 46, # 6 p. 2602 - 2608

上游产品 5
831-71-0 698-63-5 92-55-7 1673-59-2
79-19-6
下游产品 2
3237-63-6 16865-27-3

海关编码	2934999090
中文概述	2934999090. 其他杂环化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0%
申报要素	品名, 成分含量, 用途
Summary	2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

712-68-5	6473-55-8
367280-41-9	26907-62-0
26907-60-8	4447-45-4
1020-76-4	39181-40-3
26947-20-6	16784-24-0